Effects of AG3340, carboplatin, or a combination of AG3340 and carboplatin on tumor growth and animal body weights across studies
Agent | Dose | Percent tumor growth inhibitiona | Percent body weight changeb | nc |
---|---|---|---|---|
Control vehicle | 0 | −8.8 | 3 | |
AG3340 | (mg/kg/day) | |||
100 | 32.1 | −3.9 | 2 | |
200 | 39.4 | +0.3 | 2 | |
400 | 60.3 | −6.0 | 2 | |
Carboplatin | (mg/kg/wk) | |||
20 | 13.4 | −9.6 | 2 | |
40 | 29.4 | −24.5 | 2 | |
60 | 55.6 | −9.0d | 1 | |
120 | 64.8 | −21.9 | 1 | |
AG3340 | 100 | |||
+ | + | 39.1 | −14.6e | 1 |
Carboplatin | 20 | |||
AG3340 | 100 | |||
+ | + | 49.4 | −16.5e | 1 |
Carboplatin | 40 | |||
AG3340 | 400 | |||
+ | + | 62.2 | −13.0e | 1 |
Carboplatin | 40 |
a Mean value on day 38 relative to controls.
b Mean value on day 38 relative to starting weight on day 3–5 before treatment began.
c n, number of studies (with 10–12 animals/group and two tumors/animal).
d Control animals matched to this group did not suffer weight losses in this particular study (−0.5%, P > 0.05).
e Control animals corresponding to this group lost 14.9% body weight in this study (shown in Fig. 6)<$REFLINK> .